Effector Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Effector Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Effector Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Effector Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Effector Therapeutics by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $32 | 68 | 0.47 |
2023-09-30 | $18 | 30 | 0.60 |
2021-12-31 | $6.0k | 780 | 7.69 |
Top funds holding Effector Therapeutics
View all funds holding Effector Therapeutics